A study coordinated by the National Cancer Institute (NCI) suggests higher consumption of selenium may reduce the risk of advanced colorectal cancer (Cancer Epidemiol Biomarkers Prev, 15, 2:315-20, 2006).
For women with genetic mutations that increase their risk of breast and ovarian cancer, genetic testing has been a godsend. The tests allow them to learn if they carry mutations in the BRCA 1 and BRCA 2 genes, and if they do, to decide what action to take, such as stepping up screening or undergoing a preventive mastectomy.
Drinking five cups of green tea a day can reduce the risk of breast cancer by 22 per cent, claims a meta-analysis of previous studies, the same studies that the FDA recently said contained very little science to support the claims.
The European Commission has given approval for GlaxoSmithKline Plc’s Hycamtin drug to be used as a treatment for small cell lung cancer, Europe’s biggest drug maker said.
According to a recent article published in Gynecologic Oncology, a surgeon?s tendency to perform aggressive surgery greatly affects the rate of optimal surgery in patients with ovarian cancer.
According to a recent article published in the International Journal of Gynecology and Obstetrics, the addition of color Doppler imaging (CDI) to standard sonography greatly improves the accuracy of distinguishing between cancerous and non-cancerous ovarian masses prior to surgery.
Vitamin D – known to maintain normal blood levels of calcium and phosphorus – may also help in reducing cancer risk, a new study has found.
Women who drank at least two cups of tea a day had a lower risk of ovarian cancer than those who did not drink tea, according to a study in the December 12/26 issue of Archives of Internal Medicine. Evidence from laboratory studies indicates that green and black tea preparations may protect against various cancers. But few epidemiological studies have examined the relationship specifically between tea consumption and the risk of ovarian cancer, according to background information in the article.
When Dr. Bin Ye of Brigham and Women’s Hospital in Boston, and team, compared more than 600 women with ovarian cancer to 640 healthy controls, the investigators found that among the five most commonly used herbal supplements – ginkgo, echinacea, St. John’s Wort, ginseng, and chondroitin – only ginkgo was associated with a significantly reduced risk of developing ovarian cancer.
Following are the best health articles in September 2005, arranged as per viewed frequency: